Pharmaceutical Executive
Pharmaceutical Executive
Pharmaceutical Executive Podcast
Key Findings of the NIAGARA and HIMALAYA Trials
13 minutes Posted Nov 8, 2024 at 8:11 pm.
0:00
13:20
Download MP3
Show notes
In this episode of the Pharmaceutical Executive podcast, Shubh Goel, Head of Immuno-Oncology and Gastrointestinal Tumors, US Oncology Business Unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer, and much more.